Biocatalyst Market Size, Technology, Industry Demand & Regional Growth Forecast, 2032

June 26, 2025 08:48 PM AEST | By EIN Presswire
 Biocatalyst Market Size, Technology, Industry Demand & Regional Growth Forecast, 2032
Image source: EIN Presswire

The global biocatalyst market is projected to reach $2.1 billion by 2032, growing at a CAGR of 6.7% from 2023 to 2032. WILMINGTON, DE, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Biocatalyst Market by Source (Plant, Animal, Microorganism), By Type (Oxidoreductases, Transferases, Hydrolases, and Others), By End-Use Industry (pharmaceutical, food & beverage, water treatment, biofuel, and others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global biocatalyst industry was valued at $1.1 billion in 2022 and is estimated to reach $2.1 billion by 2032, exhibiting a CAGR of 6.7% from 2023 to 2032.

Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/108160

Prime Determinants of Growth:

The global biocatalyst market is driven by factors such as a rise in demand from the pharmaceutical industry and increased demand for biofuel. However, biocatalyst adoption in the chemicals sector has been relatively slower due to technical and economic constraints. This factor hinders the growth of the biocatalyst market. On the other hand, a rise in demand from emerging countries will create lucrative opportunities for the market in the coming year.

Micro-organism-based biocatalyst segment to maintain its lead position during the forecast period-

By source, the micro-organism segment accounted for the largest share in 2022, contributing to more than three-fourths of the global biocatalyst market revenue, and is expected to maintain its lead position during the forecast period. The use of microorganism-based biocatalysts offers several advantages over traditional chemical catalysts. They are often more specific, efficient, and environmentally friendly. However, the animal-based biocatalyst segment would display the fastest CAGR of 6.9% from 2023 to 2032, owing to increased demand from the food and beverage industry.

Procure Complete Report (372 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/biocatalyst-market/purchase-options

The hydrolases segment to maintains its leadership status during the forecast period-

By type, the hydrolases segment accounted for the largest share in 2022, accounting for nearly three-fourths of the global biocatalyst market revenue and is projected to maintain its leadership status during the forecast period. Hydrolases have numerous industrial applications. For example, they are used in the production of biofuels, where enzymes like cellulases and hemicelluloses are utilized to break down plant biomass into fermentable sugars. On the other hand, the transferases segment would portray the fastest CAGR of 7.0% during the forecast period. Transferases are extensively used in biotechnology and pharmaceutical research for a wide range of applications. They are essential in studying enzymatic reactions, protein modifications, and drug metabolism.

The food and beverage segment to rule the roost by 2032-

By end-use industry, the food and beverage segment accounted for the largest share in 2022, garnering more than one-third of the global biocatalyst market revenue, and is projected to rule the roost by 2032. In baking, biocatalysts such as amylases and lipases are used to break down starches and fats, respectively, leading to improved dough texture, increased volume, and enhanced crust properties. Enzymes also help extend the shelf life of baked goods by preventing retrogradation, which is the recrystallization of starch molecules. However, the biofuel segment would cite the fastest CAGR of 7.2% from 2023 to 2032. Biofuels offer an attractive alternative to fossil fuels and help reduce greenhouse gas emissions. Increased demand for biofuels has been driven by several factors, including growing concerns about climate change, the need for energy security, and the desire to reduce dependence on fossil fuels.

Have Any Query? Ask Our Expert @ https://www.alliedmarketresearch.com/purchase-enquiry/A107676

Asia-Pacific to maintain its dominance throughout the forecast period-

By region, Asia-Pacific held the highest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global biocatalyst market and is expected to maintain its dominance throughout the forecast period. The same region would also showcase the fastest CAGR of 7.3% during the forecast period. China is one of the largest consumers of biocatalysts in the Asia-Pacific region. The country has a well-established biotechnology industry and is actively investing in research and development of biocatalyst technologies. Biocatalysts are extensively used in China's pharmaceutical industry to produce APIs and pharmaceutical intermediates.

Leading Market Players: -

DSM

BASF SE

CODEXIS, INC.

AB ENZYMES

AMANO ENZYME INC.

NOVOZYMES

BIOCATALYSTS

LONZA

PROZOMIX LIMITED

DUPONT DE NEMOURS, INC.

The report provides a detailed analysis of these key players in the global biocatalyst market. These players have adopted different strategies, such as new product launches, collaborations, expansion, joint ventures, agreements, and others, to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolios, and strategic moves of market players to showcase the competitive scenario.

Access Full Summary Report: https://www.alliedmarketresearch.com/biocatalyst-market-A107676

David Correa
Allied Market Research
+ + 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.